Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

Matthew J Maurer, Lasse H. Jakobsen, Norbert Schmitz, Umar Farooq, Christopher R. Flowers Flowers, Peter de Nully Brown, Carrie A Thompson, Henrik Frederiksen, David Cunningham, Judit M Jørgensen, Viola Poeschel, Grzegorz S. Nowakowski, John Francis Seymour, Francesco Francesco Merl Francesco Merli, Corinne Haioun, Herve Ghesquieres, Marita Ziepert, Hervé Tilly, Gilles Andre Salles, Qiang ShiTarec Christoffer El-Galaly, Thomas M. Habermann

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind134
Udgave nummerSupplement 1
ISSN0006-4971
StatusUdgivet - 13. nov. 2020
BegivenhedAmerican Society of Hematology: 61st Annual Meeting (ASH) - Orlando, USA
Varighed: 7. dec. 2019 → 10. dec. 2019

Konference

KonferenceAmerican Society of Hematology: 61st Annual Meeting (ASH)
LandUSA
ByOrlando
Periode07/12/2019 → 10/12/2019

Citer dette

Maurer, M. J., Jakobsen, L. H., Schmitz, N., Farooq, U., Flowers, C. R. F., Brown, P. D. N., ... Habermann, T. M. (2020). Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC). Blood, 134(Supplement 1).
Maurer, Matthew J ; Jakobsen, Lasse H. ; Schmitz, Norbert ; Farooq, Umar ; Flowers, Christopher R. Flowers ; Brown, Peter de Nully ; Thompson, Carrie A ; Frederiksen, Henrik ; Cunningham, David ; Jørgensen, Judit M ; Poeschel, Viola ; Nowakowski, Grzegorz S. ; Seymour, John Francis ; Francesco Merli, Francesco Francesco Merl ; Haioun, Corinne ; Ghesquieres, Herve ; Ziepert, Marita ; Tilly, Hervé ; Salles, Gilles Andre ; Shi, Qiang ; El-Galaly, Tarec Christoffer ; Habermann, Thomas M. . / Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC). I: Blood. 2020 ; Bind 134, Nr. Supplement 1.
@article{e55acf91adfd462cbd2c4dde1a61b69c,
title = "Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)",
author = "Maurer, {Matthew J} and Jakobsen, {Lasse H.} and Norbert Schmitz and Umar Farooq and Flowers, {Christopher R. Flowers} and Brown, {Peter de Nully} and Thompson, {Carrie A} and Henrik Frederiksen and David Cunningham and J{\o}rgensen, {Judit M} and Viola Poeschel and Nowakowski, {Grzegorz S.} and Seymour, {John Francis} and {Francesco Merli}, {Francesco Francesco Merl} and Corinne Haioun and Herve Ghesquieres and Marita Ziepert and Herv{\'e} Tilly and Salles, {Gilles Andre} and Qiang Shi and El-Galaly, {Tarec Christoffer} and Habermann, {Thomas M.}",
year = "2020",
month = "11",
day = "13",
language = "English",
volume = "134",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "Supplement 1",

}

Maurer, MJ, Jakobsen, LH, Schmitz, N, Farooq, U, Flowers, CRF, Brown, PDN, Thompson, CA, Frederiksen, H, Cunningham, D, Jørgensen, JM, Poeschel, V, Nowakowski, GS, Seymour, JF, Francesco Merli, FFM, Haioun, C, Ghesquieres, H, Ziepert, M, Tilly, H, Salles, GA, Shi, Q, El-Galaly, TC & Habermann, TM 2020, 'Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)', Blood, bind 134, nr. Supplement 1.

Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC). / Maurer, Matthew J ; Jakobsen, Lasse H. ; Schmitz, Norbert; Farooq, Umar; Flowers, Christopher R. Flowers; Brown, Peter de Nully; Thompson, Carrie A ; Frederiksen, Henrik; Cunningham, David; Jørgensen, Judit M; Poeschel, Viola; Nowakowski, Grzegorz S.; Seymour, John Francis; Francesco Merli, Francesco Francesco Merl; Haioun, Corinne; Ghesquieres, Herve ; Ziepert, Marita ; Tilly, Hervé; Salles, Gilles Andre; Shi, Qiang; El-Galaly, Tarec Christoffer; Habermann, Thomas M. .

I: Blood, Bind 134, Nr. Supplement 1, 13.11.2020.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

AU - Maurer, Matthew J

AU - Jakobsen, Lasse H.

AU - Schmitz, Norbert

AU - Farooq, Umar

AU - Flowers, Christopher R. Flowers

AU - Brown, Peter de Nully

AU - Thompson, Carrie A

AU - Frederiksen, Henrik

AU - Cunningham, David

AU - Jørgensen, Judit M

AU - Poeschel, Viola

AU - Nowakowski, Grzegorz S.

AU - Seymour, John Francis

AU - Francesco Merli, Francesco Francesco Merl

AU - Haioun, Corinne

AU - Ghesquieres, Herve

AU - Ziepert, Marita

AU - Tilly, Hervé

AU - Salles, Gilles Andre

AU - Shi, Qiang

AU - El-Galaly, Tarec Christoffer

AU - Habermann, Thomas M.

PY - 2020/11/13

Y1 - 2020/11/13

M3 - Conference abstract in journal

VL - 134

JO - Blood

JF - Blood

SN - 0006-4971

IS - Supplement 1

ER -

Maurer MJ, Jakobsen LH, Schmitz N, Farooq U, Flowers CRF, Brown PDN et al. Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC). Blood. 2020 nov 13;134(Supplement 1).

Dokumenter og links